Purdue football player provides update on Charles Ross' departure from team
Ross' departure was a health-related issue, Odom elaborated.
On Saturday, Ross posted on X that he's retiring from football.
"To the fans, Honestly, I'm grateful for everything. God doesn't make mistakes," Ross wrote. "This wasn't my outcome for football. Dreams. Aspirations. Lovers. Fans. Doubters. This is something I cannot control. All the relationships I built from this game, I'm forever grateful. My HEALTH forever comes first. I will be medically retiring from football."
Ross transferred to Purdue in January after playing last season at USC. Ross participated in spring football camp and was with the team when fall camp began before being noticeably absent from practice.
He was expected to be a contributor offensively.
Ross had 70 career receptions for 904 yards and four touchdowns playing for Nevada, San Jose State and USC.
Sam King covers sports for the Journal & Courier. Email him at sking@jconline.com and follow him on X and Instagram @samueltking.
This article originally appeared on Lafayette Journal & Courier: Purdue football receiver Charles Ross retires due to health reasons
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
a minute ago
- Medscape
Calcium Deposition Can Increase Osteoarthritis Risk
Calcium crystal deposition may be a risk factor for knee osteoarthritis (OA), according to a new study. In an analysis including more than 6400 middle-aged to older adults, individuals with knee chondrocalcinosis were 75% more likely to develop knee OA than those without the condition at baseline. Because knee chondrocalcinosis and OA are often observed together, it is commonly considered a feature of the OA disease process, said Jean W. Liew, MD, an assistant professor of rheumatology at Boston University, Boston, and coauthor of the study. 'This study suggests that calcium crystal deposition is a cause of knee OA rather than just a consequence,' she told Medscape Medical News . The analysis included data from two independent cohorts: the Rotterdam Study (RS) and the Multicenter Osteoarthritis Study (MOST). RS enrolled individuals aged 55 years or older residing in Rotterdam, the Netherlands. MOST, which recruited participants from Birmingham, Alabama, and Iowa City, Iowa, enrolled adults aged 50-79 years with preexisting knee OA or at increased risk for OA due to overweight status, knee injury, or knee symptoms. Researchers examined the association between baseline knee chondrocalcinosis, measured via x-ray, and development of radiographic knee OA over time. Radiographic knee OA was defined as a Kellgren and Lawrence grade (KLG) ≥ 2 or if the individual had undergone knee replacement at follow-up. The analysis, published online on August 5, 2025, in Annals of the Rheumatic Diseases , included 3737 individuals from the RS cohort and 2750 individuals from the MOST cohort. At baseline in the RS cohort, 76.1% of participants had no signs of radiographic knee OA (KLG = 0), and 4.3% had knee chondrocalcinosis. For the MOST cohort, 68.5% had no signs of radiographic knee OA, and 5.0% had knee chondrocalcinosis at baseline. The analysis found that knee chondrocalcinosis increased the risk for incident radiographic knee OA after adjustment for age, sex, and BMI. The pooled odds ratio (OR) between both groups was 1.75 (95% CI, 1.25-2.27; P < .001). There were no cases of regression of chondrocalcinosis during follow-up, which suggests that chondrocalcinosis does not resolve over time, Liew and colleagues wrote. In a subgroup analysis including only individuals with KLG of 0 at baseline, the results were similar (OR = 1.77; 95% CI, 1.04-3.01; P = .035). More severe chondrocalcinosis was also associated with increased risk of developing knee OA. Commenting on the study for Medscape Medical News , Sara Tedeschi, MD, MPH, noted that these findings 'strongly suggest that [chondrocalcinosis] is a risk factor for the new development of osteoarthritis in people who don't currently have radiographic osteoarthritis.' Tedeschi is the head of crystal-induced arthritic diseases at Brigham and Women's Hospital in Boston. 'One of the unique features of this paper,' she said, 'is that they were able to look at knees that had chondrocalcinosis at baseline but no osteoarthritis at baseline and were able to follow them forward' with years of follow-up data. Treatment Options Liew now wants to explore whether treatments for inflammation related to calcium crystal deposition could also help prevent or delay progression of OA in this subset of patients. 'It's time to look at designing studies focused on this subgroup of people (with chondrocalcinosis on imaging) and testing whether treatments that work for crystal-associated arthritis like gout or calcium pyrophosphate deposition disease would also work for knee OA,' she said. 'Hints of such benefits have appeared in previous cardiovascular randomized controlled trials of colchicine, where patients receiving the drug had a lower risk of joint replacement as a secondary outcome,' noted Tedeschi. It's 'one interesting therapy to consider' for potential future trials, as are other anti-inflammatory medications like interleukin-1 inhibitors, she added.
Forbes
2 minutes ago
- Forbes
Is The Nick Woltemade To Bayern Munich Transfer Truly Dead?
Will he stay or will he go? As things stand, Nick Woltemade is going to take the field when Bayern Munich face VfB Stuttgart in the Franz-Beckenbauer-Cup on Saturday. There is also a very good chance that it will be for his current club, Stuttgart. But will it be his last game for the Swabians? The latest reports suggest that the 24-year-old striker will remain in Stuttgart for the 2025/26 season. On Wednesday, Bayern Munich and Stuttgart reopened talks about a potential transfer. Bayern, according to various reports in Germany, offered a deal worth up to €60 million ($70 million). That deal was outright rejected by Stuttgart, prompting a strong response from Woltemade's agent, Danny Bachmann from Headtrick. 'In March 2024 and most recently in mid-June, VfB made a clear commitment to a solution-oriented approach as soon as the next career step is possible,' Bachmann said to DPA. 'For an ambitious German international, a move to the record German champions and regular Champions League participants is an enormous opportunity.' The agent then directly attacked VfB Stuttgart CEO Alexander Wehrle. 'The solution demanded by Mr. Wehrle this week within a questionable deadline was delivered today with the total package from the interested party and the player's side totaling more than €60 million plus a sell-on clause,' Bachmann said. 'The [VfB] Woltemade joined VfB Stuttgart from Werder Bremen on a free transfer last season. Capable of playing as a no.9, no.10, and on the wing, Woltemade has become a bit of a unicorn. Very tall (6'5), Woltemade has incredible one-on-one skills and the ability to find solutions in tight spaces. Indeed, his underlying stats put him in the same category as Hugo Ekitiké and Alexander Isak. Ekitiké just moved in a deal worth €95 million ($110 million) from Frankfurt to Liverpool. Isak is currently embroiled in his own transfer saga with Liverpool trying to sign the Swedish forward from Newcastle. Newcastle has already rejected £110 million ($150 million). With that in mind, what is a fair price for Woltemade? Stuttgart believes that a deal in the region of €75 million ($87.5 million) is a fair price. That's in the same category then what Bayern paid for Luis Díaz. The fee also compares to what Eintracht Frankfurt received for Egyptian forward Omar Marmoush from Manchester City last winter. Bachmann seems to disagree. 'That's not only completely unfounded – especially for a domestic transfer – but is in blatant contradiction to the aforementioned agreements,' Bachmann said in his statement to DPA. When it comes to current market prices, Stuttgart's demands regarding Woltemade seem to be in line with what is paid for strikers in European football. Does that mean the deal is now dead? Stuttgart will host Bayern Munich this weekend as part of the DFL SuperCup. That weekend is usually a get-together of the big Bundesliga bosses. In other words, there will be plenty of face-to-face meetings between the two clubs. Also, Bachmann's statement suggests that Woltemade, who has trained normally with the club, could be pushing for a transfer. Although reports on Thursday suggested a deal is now on the verge of collapse, that might be a bit premature. All will depend on this weekend as Bayern might test Stuttgart's resolve one more time.
Yahoo
30 minutes ago
- Yahoo
Editorial: Saving lives no more — RFK risks us all in targeting mRNA vaccine research
Showing that his loyalty to his own anti-vax mentality is greater than his loyalty to President Donald Trump, Robert F. Kennedy Jr., the dangerous quack atop the Department of Health and Human Services, has announced that he will be rescinding a half billion dollars in grants and contracts for the development of mRNA technology and vaccines. It was mRNA that was key to both the Pfizer-BioNTech and the Moderna COVID vaccines that were created under Trump in his first term, but RFK does not like life-saving vaccines and so he's pulling the plug. Part of the problem with policymaking at the level of the federal government is that the impacts are often too large, too long-winded, too abstract to really be able to nearly encompass their full breadth, particularly for busy people who have their own immediate concerns to worry about. In this case, though, we can point to very clear, very grim and almost unavoidable repercussions directly caused by this decision: many people worldwide — including in the United States — will die deaths that could have been prevented. Setting aside all of the jargon, at its most basic level a vaccine is about allowing the body to ward off or survive pathogens that would otherwise be extremely dangerous and debilitating or kill a person outright. The model itself is far from new; inoculations in some form of another, including the basic utilization of a dead virus to create antibodies that can attack a live one, date back centuries. What's mainly changed since then is that we have only advanced our understanding and technology to keep infectious diseases from running rampant in our society. One such technological leap was the mRNA process, an innovation so significant that its pioneers won the Nobel prize. The effectiveness and the safety of this process has been well-documented in research settings, but we don't even have to parse the studies to know this because we all collectively lived it. As Trump's Operation Warp Speed produced, the first and most widespread COVID inoculations were mRNA-based vaccines, which enabled us to blunt the rampaging pandemic and much more quickly return our society to a semblance of normalcy. Those COVID vaccines have already been synthesized, but the real issue here are the ones that haven't, or even the inoculations for viruses that we have not even identified or think to be a threat today. Whether we like it or not, our relationship to infectious diseases is something akin to an arms race, in which we are constantly trying to counteract pathogens that, by dint of evolution, are constantly finding ways to elude our defenses and sicken us. We've stayed largely on top of this arms race over the last six decades or so in particular because of constant efforts that have developed sophisticated tools to fight back, including mRNA. A disarmament here for no other reason than ideologically-driven conspiracy that drives Bobby Kennedy is going to mean that we give the diseases an opening, which they will no doubt exploit to sicken and kill us. There are quite simply no two ways about it, and any pause in the research could have dire consequences, even if it is reversed later. Ongoing and sometimes multimonth or even multiyear projects will lose funding and might have to be shut down, with all their efforts wasted. There's no way to really put the genie back in the bottle so we have to stop it in the first place, which means RFK must be fired immediately or impeached and removed by Congress. Many lives hang in the balance. _____
